Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Nanosonics Limited ( (AU:NAN) ) just unveiled an update.
UBS Group AG and its related bodies corporate have notified Nanosonics Limited that they have ceased to be a substantial shareholder in the company as of 11 May 2026. The change, disclosed via a statutory notice, indicates that UBS’s voting power has fallen below the substantial holding threshold, potentially signalling a shift in the company’s institutional investor base but without further detail on the underlying transactions or strategic rationale.
The notice records that UBS previously reported its substantial holding earlier in May 2026, suggesting a relatively rapid change in its position. While the filing does not specify any impact on Nanosonics’ operations or strategy, changes in substantial shareholdings can influence market perceptions of the stock’s support among large investors and may be monitored closely by other shareholders and market participants.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.55 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is a medical technology company focused on infection prevention solutions for healthcare settings. The company is best known for its automated disinfection systems used for ultrasound probes and other reusable medical instruments, targeting hospitals and clinics concerned with reducing healthcare-associated infections.
Average Trading Volume: 795,765
Technical Sentiment Signal: Sell
Current Market Cap: A$974.2M
Learn more about NAN stock on TipRanks’ Stock Analysis page.